Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
25706 | 226 | 42.9 | 74% |
Classes in level above (level 2) |
ID, lev. above |
Publications | Label for level above |
---|---|---|
1187 | 8873 | RESTENOSIS//INTRAVASCULAR BRACHYTHERAPY//TRANILAST |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | ARTERIOSCLEROTIC PLAQUE | Author keyword | 1 | 40% | 1% | 2 |
2 | BANK MONTREAL | Address | 1 | 50% | 0% | 1 |
3 | BENZOAPYRENE DIONE | Author keyword | 1 | 50% | 0% | 1 |
4 | CELL CYCLE DEFECT | Author keyword | 1 | 50% | 0% | 1 |
5 | CIRCUMFERENTIAL TENSION | Author keyword | 1 | 50% | 0% | 1 |
6 | DNA REPAIR EFFICIENCY | Author keyword | 1 | 50% | 0% | 1 |
7 | GAS 5 | Author keyword | 1 | 50% | 0% | 1 |
8 | GSTM1 AND NAT2 GENOTYPES | Author keyword | 1 | 50% | 0% | 1 |
9 | HUMAN ATHEROSCLEROTIC PLAQUES | Author keyword | 1 | 50% | 0% | 1 |
10 | MONOCLONAL HYPOTHESIS | Author keyword | 1 | 50% | 0% | 1 |
Web of Science journal categories |
Author Key Words |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | PAH INDUCED ATHEROGENESIS | 4 | 75% | 1% | 3 |
2 | AORTIC LESIONS | 3 | 50% | 2% | 4 |
3 | CHEMICAL ATHEROGENESIS | 3 | 60% | 1% | 3 |
4 | RAS PROTOONCOGENE EXPRESSION | 1 | 100% | 1% | 2 |
5 | SMOKE EXPOSED RATS | 1 | 100% | 1% | 2 |
6 | BIPHENYL TREATED RATS | 1 | 50% | 0% | 1 |
7 | PLAQUE DNA | 1 | 50% | 0% | 1 |
8 | PROLIFERATIVE PHENOTYPE | 1 | 50% | 0% | 1 |
9 | REACTIVE GLYCATION PRODUCTS | 1 | 50% | 0% | 1 |
10 | REDUCTION COUPLES | 1 | 50% | 0% | 1 |
Journals |
Reviews |
Title | Publ. year | Cit. | Active references | % act. ref. to same field |
---|---|---|---|---|
DNA damage as a new emerging risk factor in Atherosclerosis | 2003 | 67 | 37 | 49% |
Metabolic syndrome, diabetes and atherosclerosis: Influence of gene-environment interaction | 2009 | 51 | 117 | 15% |
Bioactivation of polycyclic aromatic hydrocarbon carcinogens within the vascular wall: Implications for human atherogenesis | 2005 | 28 | 68 | 34% |
Oxidative and non-oxidative DNA damage and cardiovascular disease | 2012 | 8 | 69 | 19% |
DNA Damage and Repair in Atherosclerosis: Current Insights and Future Perspectives | 2012 | 7 | 85 | 18% |
Role of somatic mutations in vascular disease formation | 2010 | 7 | 87 | 24% |
Coronary atherosclerosis and somatic mutations: an overview of the contributive factors for oxidative DNA damage | 2003 | 79 | 165 | 14% |
GROWTH-RELATED SIGNALING AS A TARGET OF TOXIC INSULT IN VASCULAR SMOOTH-MUSCLE CELLS - IMPLICATIONS IN ATHEROGENESIS | 1995 | 10 | 58 | 38% |
Impact of cellular metabolism on the biological effects of benzo[a]pyrene and related hydrocarbons | 2001 | 135 | 110 | 12% |
DNA modifications in atherosclerosis: From the past to the future | 2013 | 8 | 72 | 7% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | BANK MONTREAL | 1 | 50% | 0.4% | 1 |
2 | NETHERLANDS ORG PL SCI METAB HLTH | 1 | 50% | 0.4% | 1 |
3 | MED ANAT HISTOL EMBRYOL | 0 | 25% | 0.4% | 1 |
4 | MICHAEL E DEBAKEY SURG R413 | 0 | 25% | 0.4% | 1 |
5 | REG HYG CENT BOHEMIA | 0 | 13% | 0.9% | 2 |
6 | ENGN BIOREACT REACT OXYGEN SPECIES | 0 | 20% | 0.4% | 1 |
7 | MAASTRICHT UMC | 0 | 20% | 0.4% | 1 |
8 | VET MED PHYSIOL PHARMACOL | 0 | 10% | 0.9% | 2 |
9 | EPIDEMIOL BIOMARKER BRANCH | 0 | 17% | 0.4% | 1 |
10 | SURGITABASHI KU | 0 | 17% | 0.4% | 1 |
Related classes at same level (level 1) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000157727 | GEN COMPARAT IMMUNOPHYSIOL//HITC//ACH50 |
2 | 0.0000138278 | SMOOTHELIN//SMTNL1//SMEMB |
3 | 0.0000128106 | GLC OXLDL//MOL VASC CELL BIOL//PATHOL AZ MIDDELHEIM |
4 | 0.0000124152 | EXPT VASC//WNC//BASIC TRANSLAT MED |
5 | 0.0000107767 | INTIMA TO MEDIA RATIO//EPIDEMIOL HLTH BEHAV SOC//BIOL DOSE SECT |
6 | 0.0000098814 | HOLLOWING//ENERGY SAVING INSTALLATIONS//GREENHOUSE SIZE AND TYPE |
7 | 0.0000094882 | D ROMS TEST//D ROMS//OXIDAT |
8 | 0.0000081837 | I COMPOUNDS//DNA ADDUCTS//P 32 POSTLABELING |
9 | 0.0000080557 | DEDINOVSK STN FLOODPLAIN MEADOW CULTURE//ELAP//KILKA |
10 | 0.0000077666 | CTHRC1//COLLAGEN TRIPLE HELIX REPEAT CONTAINING 1//CAROTID ARTERY RESTENOSIS |